Responses
Respiratory medicine
Research
Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial
Compose a Response to This Article
Other responses
No responses have been published for this article.